Same Indication

Memantine vs Rituximab

Memantine vs Rituximab: Overview

This comparison examines the pharmacological differences between Memantine and Rituximab.

Mechanism of Action

Memantine: Non-competitive NMDA receptor antagonist.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Memantine — 60-80 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Memantine — C12H21N.

Molecular Weight: Memantine — 179.3080 g/mol.

Type: Memantine — Small molecule; Rituximab — Antibody.